The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think if you're wanting if you're someone that's really got like cardiovascular disease, then like you're focusing more on a higher EPA. You want higher EPA. If you're someone that's really you've you've got a familial history of Alzheimer's disease or dementia or Parkinson's disease, brain neurogenerative disorders really focus is DHA.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I think that, you know, if you're looking the the data really shows for cardiovascular health, EPA is very important. DHA is as well. It's very it's an important it's it's it's the cell membrane component. D mostly DHA is getting into cell membranes. EPA too, but to a lesser extent. Um, if you're if you're looking for a lot of the brain benefits, Alzheimer's disease, DHA really shines there again, probably because that cell membrane component.